Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient Production of Actinium-225
TOKYO, Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world’s first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted alpha therapy (TAT).